ANA Ananda Pharma Plc

03 February 2025

ANANDA PHARMA PLC

("Ananda" or the "Company")

Ananda Pharma Appoints Viridian Capital Advisors to Advance U.S. Market Strategy

Ananda Pharma plc (AQSE: ANA), a Company focused on the development of cannabinoid-based therapies for the treatment of a range of complex conditions, today announces the appointment of Viridian Capital Advisors with immediate effect.

Viridian Capital Advisors (https://www.viridianca.com/)  is a leading New York and Aspen-based advisory boutique specialising in the cannabis and CBD industries, and has a strong track record in advising companies, raising capital, and facilitating strategic growth in the sector.

Commenting on the appointment, Melissa, CEO of Ananda Pharma, said:

"We are delighted  to partner with Viridian Capital Advisors. Their proven track record in the cannabis sector and extensive network within the U.S. investment community will be invaluable as we build our profile in the U.S. market. The U.S. market is the largest for cannabinoid-based pharmaceuticals and offers a dynamic investment landscape well-suited to our goals."

To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are: 

·    Investor Hub:

·    Instagram: https://www.instagram.com/anandapharmaplc/

·    LinkedIn:  https://www.linkedin.com/company/anandapharma

·    X: https://twitter.com/AnandaPlc

·    Investor Meet Company: https://www.investormeetcompany.com/ananda-pharma-plc/register-investor

-Ends- 

The Directors of the Company accept responsibility for the contents of this announcement. 

About Ananda Pharma 

Ananda is an AQSE-listed life sciences company focused on the research and clinical development of cannabinoid therapies for a range of complex conditions.

For more information, please visit: www.anandapharma.co.uk

https://investors.anandapharma.co.uk/link/pegVZy